交易中 10-13 11:37:52 美东时间
0.000
0.00%
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), today announced that it has priced an underwritten public offering of $400.0 million in aggregate principal amount of 6.70% notes due October 2029 (the "Notes"). The closing of the transaction is subject to custo...
10-06 04:11
The latest announcement is out from Hercules Capital, Inc. ( ($HTGC) ). On Sept...
09-18 04:52
UBS analyst Melissa Wedel upgrades Hercules Capital (NYSE:HTGC) from Neutral to Buy and raises the price target from $15.5 to $18.5.
09-01 21:00
MoonLake Immunotherapeutics press release (MLTX): Q2 GAAP EPS of -$0.84. MoonLake ended the second quarter with $537.0 million in cash, cash equivalents and short-term marketable debt securities and e...
08-10 19:12
Ladenburg Thalmann analyst Christopher Nolan maintains Hercules Capital (NYSE:HTGC) with a Buy and lowers the price target from $21 to $20.
08-01 03:12
Hercules Capital (HTGC) declares $0.40/share base quarterly and $0.07 supplemental dividend, in line with previous. Forward yield 11.69% Payable Aug. 18; for shareholders of record Aug. 11; ex-div Aug...
07-28 23:34
Hercules Capital (HTGC) priced an underwritten public offering of $325M in 6.300% notes due July 2031. The offering is expected to close on July 24, 2026. The unsecured notes will pay 6.300% annual in...
07-22 04:27
Hercules Capital, Inc. ( ($HTGC) ) has issued an announcement. In a brief regul...
07-21 20:57